Navigation Links
A New Product Offering protection against anthrax

The U.S. Food and Drug Administration is scrutinizing the claims made by a Texas businessman// who is promoting a lotion Bio- Germ .According to the claims made by the businessman Allan Lord, he says that his product can give protection from anthrax . The Bio-Germ Protection kits contain skin lotion, a nasal spray, an aerosol spray and a mask, and sell for $250 online.

According to the company, the lotion, which is made from grapefruit seeds and the oil of an Australian tree, can protect the skin of public safety workers responding to a potential terrorist attack. The aerosol spray can be used to decontaminate a room, and as a nasal spray to treat people who have inhaled spores.

Although some say that the product appears to be a breakthrough and the answer to the anthrax problem.

Initial claims on the effectiveness of the product were based on the research of Dr. John Heggers, a burn specialist at the UT Medical Branch in Galveston. Heggers published the only scientific article on Bio-Germ in an obscure online journal run by two of his former medical residents. However the journal was forced to retract the study after two scientists listed as co-authors disputed the articles findings, saying they had never read or approved it.

A number of anthrax experts who reviewed the original article for the newspaper, placed little value on Heggers claims because he failed to test spores of a highly infectious form of anthrax used by terrorists 2001. Most experts were of the opinion that Heggers tested a weak form of the bacteria sometimes found in livestock carcasses and those that could be easily killed by just rubbing alcohol.

Although Hegger has admitted that he exaggerated his claims and says he failed in adhering to the facts, Allan Lord refuses to comment on the newspapers findings, referring questions to the products' developer, who said he was unaware that Bio-Germ was being sold, as the products are still being
'"/>




Page: 1 2

Related medicine news :

1. Teens Misusing Nicotine-Replacement Products
2. Weight-loss Products Dangerous
3. The Effectiveness Of Antibacterial Products In Reducing Infection
4. Low Fat Dairy Products Ideal For Patients With Gout
5. Dairy Products Reduce Risk Of Type 2 Diabetes In Men
6. With More Appearance Conscious Consumers The Need For Slimming Products Is Rapidly Rising
7. Therapeutic Monoclonal Antibody Production Is More Profitable Than Small Molecule Drugs
8. Tea Found To Boost Insulin Production And Prevent Cataract
9. Cheese Products Withdrawn From Sales Due To Food Poisoning Hazard
10. Conroy’s May Not Be Permitted To Resume Production Soo
11. Massive Production Of Bird Flu Vaccine To Be Initiated In China
Post Your Comments:
(Date:12/2/2008)...tCall/ -- Quest Diagnostics Incorporated (NYSE: ...testing, information and services, announced that ...thcare Conference in New York City today, December...cheduled to begin at 4:00 p.m. Eastern Time. , ...affirm its 2008 guidance for revenue growth of gre...
(Date:12/2/2008)...er with aprotinin, a drug commonly used to control...y, compared with lysine analogues, according to a ...9 to be published in the January 20th issue of C...dvisory panel will meet to decide on aprotinin use...the meeting. , The study, a systematic review o...
(Date:12/2/2008)...rstCall/ - NUCRYST Pharmaceuticals Corp., a develo...t infection and inflammation, announced today that...rity shareholder, The Westaim Corporation ("Westai...areholders to consider a return of capital of US$0...s to a return of capital of approximately US$15 mi...
(Date:12/2/2008)...e Efficacy of Commercially Available Hypomethylati... Eisai Corporation of North Americ...rst clinical trial evaluating the activity of Daco...za(R) (azacitidine) in adult patients with interme...ic syndromes (MDS), a potentially life-threatening...
Breaking Medicine News(10 mins):Health News:Quest Diagnostics to Speak at the 20th Annual Piper Jaffray Healthcare Conference 2Health News:NUCRYST Receives Requisition to Call a Special Meeting of Shareholders From Majority Shareholder 2Health News:NUCRYST Receives Requisition to Call a Special Meeting of Shareholders From Majority Shareholder 3Health News:Eisai Will Initiate First Head-to-Head Study Comparing Dacogen(R) (decitabine for injection) and Vidaza(R) (azacitidine) in Patients with Myelodysplastic Syndromes 2Health News:Eisai Will Initiate First Head-to-Head Study Comparing Dacogen(R) (decitabine for injection) and Vidaza(R) (azacitidine) in Patients with Myelodysplastic Syndromes 3
... the researchers at the McMaster University includ...till remains controversial.// Sports drink play a...s carbohydrates and sodium. Carbohydrates provide ...ntains fluid balance in the body. The study, which...
...ave discovered that fibrin fibers could stretch to...riginal state, while some could even stretch to si...Fibrin involved in blood clotting is developed in ...inogen. When an injury occurs fibrin is deposited...
...iday banned the sale and consumption of soft drink...e have imposed a ban on soft drinks in all educati...an Education Minister Ghanshyam Tiwari told IANS h...o 100,000 government and private institutes where ...
... popular supermarket chains have announced that th...in their products.// Trans fat was recently in th...rt diseases. It is also thought to cause cancers a... are Sainsbury, Asda and Tesco. It was found that ...
Other Medicine News:Health News:Is Addition Of Proteins In The Sports Drink Beneficial? 2
(Date:12/1/2008)...e Call Scheduled for Tuesday, December 9 at 11:00 ..., , SOUTH SAN FRANCISCO, Calif., Dec. 1 /...Inc. (Nasdaq: SNSS ), a biopharmaceutical compan... of new oncology therapeutics, today announced new...id leukemia (AML) will be presented during the 50t...
(Date:11/28/2008)..., Germany, November 28 German biot...ship in specialized HIV monitoring and,AIDS patie...ng countries. In,the year 2008, 2.5 million patie...obust and highly affordable "CyFlow" system, suppo...ith HIV/AIDS. Due to introduction of the,Partec i...
(Date:11/26/2008)...ed to 406 Subjects , , FRANKLIN, Mass., Nov...TC Bulletin Board: PLCSF) announced today that it ...Drug Administration (FDA) for its U.S. pivotal tri...alGuard System(TM) and associated therapy in the ..., , The FDA also approved PLC,s request to ...
(Date:11/25/2008)...ANCISCO, Calif., Nov. 25 ... a biopharmaceutical company focused on,innovativ... be exploring,strategic alternatives for its prec...ompany to focus its resources on the clinical deve..., and to support the initial commercialization of,...
Breaking Medicine Technology:Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 2Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 3STERIS Corporation Announces New 24300 Million Share Repurchase Authorization 14383 1STERIS Corporation Announces New 24300 Million Share Repurchase Authorization 14383 2STERIS Corporation Announces New 24300 Million Share Repurchase Authorization 14383 3SemBioSys GLA Partner Enters Strategic Alliance for the Sales and Marketing of GLA Rich Safflower Oil 3970 1SemBioSys GLA Partner Enters Strategic Alliance for the Sales and Marketing of GLA Rich Safflower Oil 3970 2SemBioSys GLA Partner Enters Strategic Alliance for the Sales and Marketing of GLA Rich Safflower Oil 3970 3The ABCs of childhood zs 3A Snoring may be chronic despite surgery 14382 1The ABCs of childhood zs 3A Snoring may be chronic despite surgery 14382 2Low exposure to asbestos like mineral from Montana vermiculite may up lung disease risk 2504 1Low exposure to asbestos like mineral from Montana vermiculite may up lung disease risk 2504 2
...ll/ - Research,collaborators with Oncolytics Biote...poster presentation covering REOLYSIN(R),clinical ...ology,(ASCO) Annual Meeting, to be held June 1-5, ...ncolytics, U.K. Phase I systemic,administration tr...ase I Study of,Wild-Type Oncolytic Reovirus Admini...
...007 - A therapeutic,vaccine developed by the Germa...ew hope for cancer patients. The results of a,succ...d to an,international audience at the Annual Confe...y (ASCO) in Chicago, USA. ASCO is the,most importa...,world-wide., The active substance VPM4001, an imm...
Other Medicine Technology:Oncolytics Biotech Inc.'s Research Collaborators to Present,REOLYSIN Clinical Trial Data at ASCO Conference 2Vakzine Projekt Management Reports Positive Clinical Trial Results,With Their Therapeutic Prostate Cancer Vaccine VPM4001 2
...e BP monitor is designed to automatically measure ...BP along with heart rate. It's a Blood Pressure mo...ergometer and pharmacological stress test environm...ronments., ,Tango excels where other BP monit...
BD Visiswab Cotton Swab
...l, Philips Zymed 1810 Series offers retrospective ... the operator the flexibility to adjust the algori...application beyond the basic 1810 and you have eve...matic style that best meets the challenges of each...
...s STG for PC captures, displays, replays and analy...be effective in evaluating heart illnesses, pneumo...ase.,It provides objective evidence as a complem...time-expanded waveform displays, Phonocardiogra...
Medicine Products: